RÉSUMÉ
Cullin-1-RING ubiquitin ligases (CRL1) or SCF1 (SKP1-CUL1-RBX1) E3 ubiquitin ligases are the largest and most extensively investigated class of E3 ligases in mammals that regulate fundamental processes, such as the cell cycle and proliferation. These enzymes are multiprotein complexes comprising SKP1, CUL1, RBX1, and an F-box protein that acts as a specificity factor by interacting with SKP1 through its F-box domain and recruiting substrates via other domains. E3 ligases are important players in the ubiquitination process, recognizing and transferring ubiquitin to substrates destined for degradation by proteasomes or processing by deubiquitinating enzymes. The ubiquitin-proteasome system (UPS) is the main regulator of intracellular proteolysis in eukaryotes and is required for parasites to alternate hosts in their life cycles, resulting in successful parasitism. Leishmania UPS is poorly investigated, and CRL1 in L. infantum, the causative agent of visceral leishmaniasis in Latin America, is yet to be described. Here, we show that the L. infantum genes LINF_110018100 (SKP1-like protein), LINF_240029100 (cullin-like protein-like protein), and LINF_210005300 (ring-box protein 1 -putative) form a LinfCRL1 complex structurally similar to the H. sapiens CRL1. Mass spectrometry analysis of the LinfSkp1 and LinfCul1 interactomes revealed proteins involved in several intracellular processes, including six F-box proteins known as F-box-like proteins (Flp) (data are available via ProteomeXchange with identifier PXD051961). The interaction of LinfFlp 1-6 with LinfSkp1 was confirmed, and using in vitro ubiquitination assays, we demonstrated the function of the LinfCRL1(Flp1) complex to transfer ubiquitin. We also found that LinfSKP1 and LinfRBX1 knockouts resulted in nonviable L. infantum lineages, whereas LinfCUL1 was involved in parasite growth and rosette formation. Finally, our results suggest that LinfCul1 regulates the S phase progression and possibly the transition between the late S to G2 phase in L. infantum. Thus, a new class of E3 ubiquitin ligases has been described in L. infantum with functions related to various parasitic processes that may serve as prospective targets for leishmaniasis treatment.
Sujet(s)
Cullines , Leishmania infantum , Leishmania infantum/métabolisme , Leishmania infantum/enzymologie , Cullines/métabolisme , Cullines/génétique , Protéines de protozoaire/métabolisme , Protéines de protozoaire/génétique , Ubiquitination , Leishmaniose viscérale/parasitologie , Leishmaniose viscérale/métabolisme , Humains , Ubiquitin-protein ligases/métabolisme , Ubiquitin-protein ligases/génétique , Proteasome endopeptidase complex/métabolismeRÉSUMÉ
Cell migration is a complex process that involves coordinated changes in membrane transport and actin cytoskeleton dynamics. Ras-like small monomeric GTPases, such as Rap2, play a key role in regulating actin cytoskeleton dynamics and cell adhesions. However, how Rap2 function, localization, and activation are regulated during cell migration is not fully understood. We previously identified the small GTPase Rab40b as a regulator of breast cancer cell migration. Rab40b contains a suppressor of cytokine signaling (SOCS) box, which facilitates binding to Cullin5, a known E3 ubiquitin ligase component responsible for protein ubiquitylation. In this study, we show that the Rab40b/Cullin5 complex ubiquitylates Rap2. Importantly, we demonstrate that ubiquitylation regulates Rap2 activation as well as recycling of Rap2 from the endolysosomal compartment to the lamellipodia of migrating breast cancer cells. Based on these data, we propose that Rab40b/Cullin5 ubiquitylates and regulates Rap2-dependent actin dynamics at the leading edge, a process that is required for breast cancer cell migration and invasion.
Sujet(s)
Tumeurs du sein , Cullines , Protéines G rap , Cytosquelette d'actine , Tumeurs du sein/génétique , Tumeurs du sein/métabolisme , Mouvement cellulaire , Cullines/métabolisme , Femelle , Humains , Pseudopodes/métabolisme , Facteurs de transcription/métabolisme , Ubiquitin-protein ligases/métabolisme , Ubiquitination , Protéines G rap/métabolismeRÉSUMÉ
OBJECTIVE: Emerging studies highlight the crucial effects of microRNAs on cancer initiation and malignant progression of various tumors. This study focused on the biological effect of miR-377-3p on CUL1 and epithelial-mesenchymal transition (EMT) and Wnt/ß-catenin pathways in osteosarcoma (OS). METHODS: We performed quantitative real-time polymerase chain reaction (qRT-PCR) to analyze miR-377-3p and CUL1 expression levels in OS tissues and MG-63 cells. Then, cell counting kit (CCK)-8 and Transwell assay were used to examine the functions of miR-377-3p in OS cell growth and metastasis abilities. Meanwhile, luciferase reporter assay was used to validate CUL1 as direct target of miR-377-3p. qRT-PCR and Western blot were then carried out to detect the impact of miR-377-3p on EMT and Wnt/ß-catenin pathways. Tumor xenograft models were established to further examine the effects of miR-377-3p on OS tumorigenesis in vivo. RESULTS: miR-377-3p downregulation was frequently identified in OS tissues and cells, which was associated with worse prognosis of OS patients. Functional experiments showed miR-377-3p restoration could dramatically repress OS cell growth and migration by regulation of EMT and Wnt/ß-catenin pathways. Moreover, luciferase reporter assay revealed that CUL1 acted as a functional target of miR-377-3p. Additionally, the elevated CUL1 expressions in OS tissues also indicated poor prognosis of OS patients. Furthermore, the OS tumor growth was also obviously inhibited by miR-377-3p overexpression in vivo. CONCLUSIONS: Collectively, all the above findings revealed that miR-377-3p exerted anti-OS functions via CUL1 and EMT and Wnt/ß-catenin pathways. These results may contribute to the development of clinical OS treatment.
Sujet(s)
Tumeurs osseuses/métabolisme , Cullines/métabolisme , microARN/métabolisme , Ostéosarcome/métabolisme , Voie de signalisation Wnt , Animaux , Tumeurs osseuses/mortalité , Tumeurs osseuses/anatomopathologie , Lignée cellulaire tumorale , Évolution de la maladie , Régulation négative , Transition épithélio-mésenchymateuse , Gènes rapporteurs , Hétérogreffes , Humains , Luciferases/génétique , Souris , Souris de lignée BALB C , Souris nude , Transplantation tumorale , Ostéosarcome/mortalité , Ostéosarcome/anatomopathologie , Ostéosarcome/secondaire , Pronostic , RT-PCRRÉSUMÉ
The physiological role of the shorter isoform of with no lysine kinase (WNK)1 that is exclusively expressed in the kidney (KS-WNK1), with particular abundance in the distal convoluted tubule, remains elusive. KS-WNK1, despite lacking the kinase domain, is nevertheless capable of stimulating the NaCl cotransporter, apparently through activation of WNK4. It has recently been shown that a less severe form of familial hyperkalemic hypertension featuring only hyperkalemia is caused by missense mutations in the WNK1 acidic domain that preferentially affect cullin 3 (CUL3)-Kelch-like protein 3 (KLHL3) E3-induced degradation of KS-WNK1 rather than that of full-length WNK1. Here, we show that full-length WNK1 is indeed less impacted by the CUL3-KLHL3 E3 ligase complex compared with KS-WNK1. We demonstrated that the unique 30-amino acid NH2-terminal fragment of KS-WNK1 is essential for its activating effect on the NaCl cotransporter and recognition by KLHL3. We identified specific amino acid residues in this region critical for the functional effect of KS-WNK1 and KLHL3 sensitivity. To further explore this, we generated KLHL3-R528H knockin mice that mimic human mutations causing familial hyperkalemic hypertension. These mice revealed that the KLHL3 mutation specifically increased expression of KS-WNK1 in the kidney. We also observed that in wild-type mice, the expression of KS-WNK1 was only detectable after exposure to a low-K+ diet. These findings provide new insights into the regulation and function of KS-WNK1 by the CUL3-KLHL3 complex in the distal convoluted tubule and indicate that this pathway is regulated by dietary K+ levels.NEW & NOTEWORTHY In this work, we demonstrated that the kidney-specific isoform of with no lysine kinase 1 (KS-WNK1) in the kidney is modulated by dietary K+ and activity of the ubiquitin ligase protein Kelch-like protein 3. We analyzed the role of different amino acid residues of KS-WNK1 in its activity against the NaCl cotransporter and sensitivity to Kelch-like protein 3.
Sujet(s)
Protéines adaptatrices de la transduction du signal/métabolisme , Rein/enzymologie , Protéines des microfilaments/métabolisme , Potassium alimentaire/métabolisme , Pseudohypoaldostéronisme/enzymologie , Protéine kinase déficiente en lysine WNK-1/métabolisme , Protéines adaptatrices de la transduction du signal/génétique , Animaux , Cullines/métabolisme , Stabilité enzymatique , Femelle , Rein/physiopathologie , Souris de lignée C57BL , Souris transgéniques , Protéines des microfilaments/génétique , Mutation , Motifs et domaines d'intéraction protéique , Protein-Serine-Threonine Kinases/génétique , Protein-Serine-Threonine Kinases/métabolisme , Protéolyse , Pseudohypoaldostéronisme/génétique , Pseudohypoaldostéronisme/physiopathologie , Membre-3 de la famille-12 des transporteurs de solutés/génétique , Membre-3 de la famille-12 des transporteurs de solutés/métabolisme , Protéine kinase déficiente en lysine WNK-1/déficit , Protéine kinase déficiente en lysine WNK-1/génétique , Xenopus laevisRÉSUMÉ
Among the members of the ubiquitin-like (Ubl) protein family, neural precursor cell expressed developmentally down-regulated protein 8 (NEDD8) is the closest in sequence to ubiquitin (57% identity). The two modification mechanisms and their functions, however, are highly distinct and the two Ubls are not interchangeable. A complex network of interactions between modifying enzymes and adaptors, most of which are specific while others are promiscuous, ensures selectivity. Many domains that bind the ubiquitin hydrophobic patch also bind NEDD8 while no domain that specifically binds NEDD8 has yet been described. Here, we report an unbiased selection of domains that bind ubiquitin and/or NEDD8 and we characterize their specificity/promiscuity. Many ubiquitin-binding domains bind ubiquitin preferentially and, to a lesser extent, NEDD8. In a few cases, the affinity of these domains for NEDD8 can be increased by substituting the alanine at position 72 with arginine, as in ubiquitin. We have also identified a unique domain, mapping to the carboxyl end of the protein KHNYN, which has a stark preference for NEDD8. Given its ability to bind neddylated cullins, we have named this domain CUBAN (Cullin-Binding domain Associating with NEDD8). We present here the solution structure of the CUBAN domain both in the isolated form and in complex with NEDD8. The results contribute to the understanding of the discrimination mechanism between ubiquitin and the Ubl. They also provide new insights on the biological role of a ill-defined protein, whose function is hitherto only predicted.
Sujet(s)
Cullines/métabolisme , Protéine NEDD8/métabolisme , Ubiquitines/métabolisme , Séquence d'acides aminés , Cellules cultivées , Humains , Protéine NEDD8/composition chimique , Protéine NEDD8/génétique , Liaison aux protéines , Conformation des protéines , Domaines protéiques , Similitude de séquences , UbiquitinationRÉSUMÉ
The renal thiazide-sensitive NaCl cotransporter (NCC) is the major salt transport pathway in the distal convoluted tubule of the mammalian nephron. NCC activity is critical for modulation of arterial blood pressure and serum potassium levels. Reduced activity of NCC in genetic diseases results in arterial hypotension and hypokalemia, while increased activity results in genetic diseases featuring hypertension and hyperkalemia. Several hormones and physiological conditions modulate NCC activity through a final intracellular complex pathway involving kinases and ubiquitin ligases. A substantial amount of work has been conducted to understand this pathway in the last 15 yr, but advances over the last 3 yr have helped to begin to understand how these regulatory proteins interact with each other and modulate the activity of this important cotransporter. In this review, we present the current model of NCC regulation by the Cullin 3 protein/Kelch-like 3 protein/with no lysine kinase/STE20-serine-proline alanine-rich kinase (CUL3/KELCH3-WNK-SPAK) pathway. We present a review of all genetically altered mice that have been used to translate most of the proposals made from in vitro experiments into in vivo observations that have helped to elucidate the model at the physiological level. Many questions have been resolved, but some others will require further models to be constructed. In addition, unexpected observations in mice have raised new questions and identified regulatory pathways that were previously unknown.
Sujet(s)
Rein/métabolisme , Protein-Serine-Threonine Kinases/métabolisme , Membre-3 de la famille-12 des transporteurs de solutés/métabolisme , Protéines adaptatrices de la transduction du signal , Animaux , Cullines/génétique , Cullines/métabolisme , Modèles animaux de maladie humaine , Prédisposition génétique à une maladie , Syndrome de Gitelman/enzymologie , Syndrome de Gitelman/génétique , Humains , Souris transgéniques , Protéines des microfilaments/génétique , Protéines des microfilaments/métabolisme , Phénotype , Protein-Serine-Threonine Kinases/génétique , Pseudohypoaldostéronisme/enzymologie , Pseudohypoaldostéronisme/génétique , Transduction du signal , Membre-3 de la famille-12 des transporteurs de solutés/génétique , Protéine kinase déficiente en lysine WNK-1/génétique , Protéine kinase déficiente en lysine WNK-1/métabolismeRÉSUMÉ
In order to establish infection, bacterial pathogens modulate host cellular processes by using virulence factors, which are delivered from the bacteria to the host cell leading to cellular reprogramming. In this context, several pathogens regulate the ubiquitin proteasome system in order to regulate the cellular effectors required for their successful colonization and persistance. In this study, we investigated how Helicobacter pylori affect the ubiquitination of the host proteins to achieve the adherence to the cells, using AGS gastric epithelial cells cultured with H. pylori strains, H. pylori 26695 and two isogenic mutants H. pylori cag::cat and vacA::apha3, to characterize the ability of H. pylori to reprogram the ubiquitin proteasome systems. The infection assays suggest that the ubiquitination of the total proteins does not change when cells were co-culture with H. pylori. We also found that the proteasome activity is necessary for H. pylori adhesion to AGS cells and the adherence increases when the level of KCTD5, an adaptor of Cullin-3, decrease. Moreover, we found that KCTD5 is ubiquitinated and degraded by the proteasome system and that CagA and VacA played no role on reducing KCTD5 levels. Furthermore, H. pylori impaired KCTD5 ubiquitination and did not increase global proteasome function. These results suggest that H. pylori affect the ubiquitin-proteasome system (UPS) to facilitate the adhesion of this microorganism to establish stable colonization in the gastric epithelium and improve our understanding of how H. pylori hijack host systems to establish the adherence.
Sujet(s)
Adhésines bactériennes/métabolisme , Infections à Helicobacter/métabolisme , Helicobacter pylori/pathogénicité , Canaux potassiques/métabolisme , Proteasome endopeptidase complex/métabolisme , Transduction du signal , Ubiquitine/métabolisme , Acétylcystéine/analogues et dérivés , Acétylcystéine/métabolisme , Antigènes bactériens/métabolisme , Protéines bactériennes/métabolisme , Lignée cellulaire , Techniques de coculture , Cullines/métabolisme , Cellules épithéliales/métabolisme , Cellules épithéliales/microbiologie , Muqueuse gastrique/métabolisme , Muqueuse gastrique/microbiologie , Helicobacter pylori/croissance et développement , Helicobacter pylori/physiologie , Interactions hôte-pathogène/physiologie , Humains , Lysosomes , Facteurs de virulence/métabolismeRÉSUMÉ
UNLABELLED: Introduction and Aim. TGF-ß signalling is involved in pathogenesis and progress of hepatocellular carcinoma (HCC). This bioinformatics study consequently aims to determine the underlying molecular mechanism of TGF- ß activation in HCC cells. MATERIAL AND METHODS: Dataset GSE10393 was downloaded from Gene Expression Omnibus, including 2 Huh-7 (HCC cell line) samples treated by TGF- ß (100 pmol/L, 48 h) and 2 untreated samples. Differentially expressed genes (DEGs) were screened using Limma package (false discovery rate < 0.05 and |log2 fold change| > 1.5), and then enrichment analyses of function, pathway, and disease were performed. In addition, protein-protein interaction (PPI) network was constructed based on the PPI data from multiple databases including INACT, MINT, BioGRID, UniProt, BIND, BindingDB, and SPIKE databases. Transcription factor (TF)-DEG pairs (Bonferroni adjusted p-value < 0.01) from ChEA database and DEG-DEG pairs were used to construct TF-DEG regulatory network. Furthermore, TF-pathway-DEG complex network was constructed by integrating DEG-DEG pairs, TF-DEG pairs, and DEG-pathway pairs. RESULTS: Totally, 209 DEGs and 30 TFs were identified. The DEGs were significantly enriched in adhesion-related functions. PPI network indicted hub genes such as CUL4B and NEDD4. According to the TF-DEG regulatory network, the two hub genes were targeted by SMAD2, SMAD3, and HNF4A. Besides, the 11 pathways in TF-pathway-DEG network were mainly enriched by UGT1A family and CYP3A7, which were predicted to be regulated by SMAD2, SMAD3, SOX2, TP63, and HNF4A. CONCLUSIONS: TGF- ß might influence biological processes of HCC cells via SMAD2/SMAD3-NEDD4, HNF4A-CUL4B/NEDD4, SOX2/TP63/HNF4A-CYP3A7, and SMAD2/SMAD3/SOX2/TP63/HNF4A-UGT1As regulatory pathways.
Sujet(s)
Carcinome hépatocellulaire/génétique , Cullines/génétique , Complexes de tri endosomique requis pour le transport/génétique , Glucuronosyltransferase/génétique , Tumeurs du foie/génétique , Facteur de croissance transformant bêta/métabolisme , Ubiquitin-protein ligases/génétique , Carcinome hépatocellulaire/métabolisme , Adhérence cellulaire/génétique , Lignée cellulaire tumorale , Cullines/métabolisme , Cytochrome P-450 CYP3A/génétique , Cytochrome P-450 CYP3A/métabolisme , Bases de données génétiques , Complexes de tri endosomique requis pour le transport/métabolisme , Analyse de profil d'expression de gènes , Glucuronosyltransferase/métabolisme , Facteur nucléaire hépatocytaire HNF-4/génétique , Facteur nucléaire hépatocytaire HNF-4/métabolisme , Humains , Tumeurs du foie/métabolisme , Ubiquitine protéine ligases NEDD4 , Cartes d'interactions protéiques , Facteurs de transcription SOX-B1/génétique , Facteurs de transcription SOX-B1/métabolisme , Transduction du signal/génétique , Protéine Smad2/génétique , Protéine Smad2/métabolisme , Protéine Smad-3/génétique , Protéine Smad-3/métabolisme , Facteurs de transcription/génétique , Facteurs de transcription/métabolisme , Protéines suppresseurs de tumeurs/génétique , Protéines suppresseurs de tumeurs/métabolisme , Ubiquitin-protein ligases/métabolismeRÉSUMÉ
The use of carboplatin in cancer chemotherapy is limited by the emergence of drug resistance. To understand the molecular basis for this resistance, a chemogenomic screen was performed in 53 yeast mutants that had previously presented strong sensitivity to this widely used anticancer agent. Thirty-four mutants were responsive to carboplatin, and from these, 21 genes were selected for further studies because they have human homologues. Sixty percent of these yeast genes possessed human homologues which encoded proteins that interact with cullin scaffolds of ubiquitin ligases, or whose mRNA are under the regulation of Human antigen R (HuR) protein. Both HuR and cullin proteins are regulated through NEDDylation post-translational modification, and so our results indicate that inhibition of this process should sensitise resistant tumour cells to carboplatin. We showed that treatment of a tumour cell line with MLN4924, a NEDDylation inhibitor, overcame the resistance to carboplatin. Our data suggest that inhibition of NEDDylation may be a useful strategy to resensitise tumour cells in patients that have acquired carboplatin resistance.
Sujet(s)
Carboplatine/pharmacologie , Cullines/génétique , Résistance aux médicaments antinéoplasiques/génétique , Protéine-1 similaire à ELAV/génétique , Saccharomyces cerevisiae/effets des médicaments et des substances chimiques , Saccharomyces cerevisiae/génétique , Lignée cellulaire tumorale/effets des médicaments et des substances chimiques , Chromosomes humains de la paire 1 , Cullines/métabolisme , Cyclopentanes/pharmacologie , Résistance des champignons aux médicaments/effets des médicaments et des substances chimiques , Résistance des champignons aux médicaments/physiologie , Résistance aux médicaments antinéoplasiques/effets des médicaments et des substances chimiques , Protéine-1 similaire à ELAV/métabolisme , Femelle , Analyse de profil d'expression de gènes , Humains , Mutation , Tumeurs de l'ovaire/traitement médicamenteux , Tumeurs de l'ovaire/génétique , Pyrimidines/pharmacologie , Ubiquitin-activating enzymes/antagonistes et inhibiteurs , Ubiquitin-activating enzymes/génétique , Ubiquitin-activating enzymes/métabolismeRÉSUMÉ
NEDD8 is an ubiquitin-like molecule that covalently binds to target proteins through an enzymatic cascade analogous to ubiquitylation. This modifier is known to bind to p53 and p73, as well as all Cullin family proteins, which are essential components of Skp1/Cul-1/F-box protein (SCF)-like Ub ligase complexes. Here, we focused on a genomic analysis of the genes involved in the NEDD8 conjugation pathway in Schistosoma mansoni. The results revealed seven genes related to NEDD8 conjugation that are conserved in Schistosoma japonicum, Caenorhabditis elegans, Drosophila melanogaster and Homo sapiens. We performed quantitative RT-PCR (qRT-PCR), which showed differential profiles for Smnedd8, Smapp1, Smuba3, Smube2f, Smdcn1, Smrbx and Smsenp8 throughout the life cycle of S. mansoni. Upregulation was observed in 3-day-old schistosomula and adult worms for all analysed genes. We also analysed the transcription levels of Cullin family members Smp63 and Smp73, and observed upregulation in early schistosomula, while cercariae and adult worms showed expression levels similar to one another. Taken together, these results suggest that the NEDDylation/DeNEDDylation pathway controls important cellular regulators during worm development from cercariae to schistosomula and, finally, to adult.
Sujet(s)
Cullines/métabolisme , Maturation post-traductionnelle des protéines , Schistosoma mansoni/métabolisme , Ubiquitin-conjugating enzymes/génétique , Ubiquitines/génétique , Séquence d'acides aminés , Animaux , Biomphalaria , Cullines/génétique , Régulation de l'expression des gènes , Génomique , Protéines d'helminthes/génétique , Protéines d'helminthes/métabolisme , Souris , Souris de lignée BALB C , Données de séquences moléculaires , Phylogenèse , Structure tertiaire des protéines , ARN des helminthes/génétique , Schistosoma mansoni/enzymologie , Schistosoma mansoni/génétique , Schistosoma mansoni/croissance et développement , Schistosomiase à Schistosoma mansoni/parasitologie , Alignement de séquences , Transcriptome , Ubiquitin-conjugating enzymes/métabolisme , Ubiquitin-protein ligase complexes/génétique , Ubiquitin-protein ligase complexes/métabolisme , Ubiquitines/métabolismeRÉSUMÉ
AtFBS1 is an F-box protein whose transcript accumulates in response to biotic and abiotic stresses. Previous evidence suggests that a postranscriptional event regulates AtFBS1 expression [1]. We now found that AtFBS1 interacts with 14-3-3 proteins through its amino-terminus and the F-box motif. Deletion of any of these regions abolishes the interaction between AtFBS1 and 14-3-3 proteins. On the other hand, the treatment with the proteasome inhibitor MG132 or the deletion of the F-box from AtFBS1 increases ß-glucuronidase (GUS) activity in plants containing a translational fusion of AtFBS1 with the GUS reporter gene, indicating that AtFBS1 is degraded by the 26S proteasome. MG132 treatment of seedlings containing a gene fusion between AtFBS1 and the TAP (Tandem Affinity Purification) cassette causes an increase in the half-life of the protein. In an attempt to understand the role of 14-3-3 interactions, we treated Arabidopsis seedlings with 5-aminoimidazole-4-carboxamide-1-ß-d-ribofuranosyl 5'-monophosphate (AICAR), an inhibitor of 14-3-3 client interactions. We observed an increase in AtFBS1-TAP stability as a consequence of AICAR treatment. Based on these data we propose that 14-3-3 proteins promote the dimerization of SCF(AtFBS1). This also may enhance the AtFBS1 autoubiquitination activity and its degradation by the 26S proteasome. AICAR also affects Cullin1 (CUL1) modification by RUB1, which would provide an additional element to the effect of this compound on AtFBS1 stability.
Sujet(s)
Protéines 14-3-3/métabolisme , 5-Amino-imidazole-4-carboxamide/analogues et dérivés , Protéines d'Arabidopsis/métabolisme , Arabidopsis/métabolisme , Protéines F-box/métabolisme , Proteasome endopeptidase complex/métabolisme , Ribonucléotides/pharmacologie , Stress physiologique , Protéines 14-3-3/antagonistes et inhibiteurs , Adaptation physiologique , 5-Amino-imidazole-4-carboxamide/pharmacologie , Arabidopsis/effets des médicaments et des substances chimiques , Arabidopsis/génétique , Cullines/métabolisme , Motifs F-box , Gènes de plante , Glucuronidase/génétique , Glucuronidase/métabolisme , Leupeptines/pharmacologie , Inhibiteurs du protéasome/pharmacologie , Multimérisation de protéines , Stabilité protéique , Protéolyse , Plant/effets des médicaments et des substances chimiques , Plant/métabolisme , Ubiquitination , Ubiquitines/métabolismeRÉSUMÉ
The SCF (Skp1-Cul1-F-box) complex is one of the several E3 ligase enzymes and it catalyzes protein ubiquitination and degradation by the 26S proteasome. Rbx1 is a member of the SCF complex in humans and HRT1 is its yeast orthologue. A cDNA encoding a Schistosoma mansoni Rbx1 homolog was cloned and functionally characterized. Heterologous functional complementation in yeast showed that the worm SmRbx gene was able to complement the HRT1yeast null mutation. Gene deletion constructs for N- and C-termini truncated proteins were used to transform hrt1(-) yeast mutant strains, allowing us to observe that regions reported to be involved in the interaction with cullin1 (Cul1) were essential for SmRbx function. Yeast two-hybrid assays using SmRbx and yeast Cul1 confirmed that SmRbx, but not the mutant SmRbxDelta24N, lacking the N-terminus of the protein, was capable of interacting with Cul1. These results suggest that SmRbx protein is involved in the SCF complex formation.